Fouadhassan

Moderna testing 70$

做多
Fouadhassan 已更新   
NASDAQ:MRNA   Moderna, Inc.
Moderna has benefit a lot from COVID time and coming with Vaccine is huge win lining the way for more products with mRNA tech , breaking 70$ it may go back up with good news on test results that, so far no major side effect found i hope they make success , this will justify easy 130$
交易结束:到达目标:
target reached at 90 , 112 and 146 closed and waiting entry back near 100 $
交易结束:到达目标:
recent target 185 reached

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。